Literature DB >> 10655418

PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.

T Alarcón1, D Domingo, N Prieto, M López-Brea.   

Abstract

Twenty-five clarithromycin-resistant Helicobacter pylori strains (selected by agar dilution) were studied to detect A2142G and A2143G mutations in the 23S rRNA gene by a PCR-restriction fragment length polymorphism method and an A2142C mutation by PCR using a 3'-mismatched specific primer. A 700-bp amplified fragment was obtained by the mismatched PCR only in strains without an A2142G or A2143G mutation, indicating that those strains had the A2142C mutation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655418      PMCID: PMC86249     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  High frequency of mutations at position 2144 of the 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains isolated in Spain.

Authors:  D Domingo; T Alarcón; J C Sanz; I Sánchez; M López-Brea
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

2.  Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.

Authors:  J I Ross; E A Eady; J H Cove; C E Jones; A H Ratyal; Y W Miller; S Vyakrnam; W J Cunliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.

Authors:  J Versalovic; M S Osato; K Spakovsky; M P Dore; R Reddy; G G Stone; D Shortridge; R K Flamm; S K Tanaka; D Y Graham
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

Review 4.  Resistance of Helicobacter pylori to antibiotics.

Authors:  F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

Review 5.  Antibiotic resistance problems with Helicobacter pylori.

Authors:  T Alarcón; D Domingo; M López-Brea
Journal:  Int J Antimicrob Agents       Date:  1999-06       Impact factor: 5.283

6.  Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.

Authors:  H Wurzer; L Rodrigo; D Stamler; A Archambault; T Rokkas; N Skandalis; R Fedorak; F Bazzoli; E Hentschel; P Mora; A Archimandritis; F Megraud
Journal:  Aliment Pharmacol Ther       Date:  1997-10       Impact factor: 8.171

7.  Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.

Authors:  D E Taylor; Z Ge; D Purych; T Lo; K Hiratsuka
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 8.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

9.  Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase.

Authors:  M Pina; A Occhialini; L Monteiro; H P Doermann; F Mégraud
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; A B Brinkman; E J Kuipers; C M Vandenbroucke-Grauls; J G Kusters
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more
  14 in total

1.  Clarithromycin resistance to Mycobacterium abscessus.

Authors:  B A Brown-Elliott; R J Wallace
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh.

Authors:  Rasel Khan; Shamsun Nahar; Jinath Sultana; Mian Mashhud Ahmad; Motiur Rahman
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

4.  Helicobacter pylori antibiotic resistance in Iran.

Authors:  Marjan Mohammadi; Delaram Doroud; Nazanin Mohajerani; Sadegh Massarrat
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates.

Authors:  Carla Fontana; Marco Favaro; Silvia Minelli; Anna Angela Criscuolo; Antonio Pietroiusti; Alberto Galante; Cartesio Favalli
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.

Authors:  Mubarak S Alfaresi; Abida A Elkoush
Journal:  Indian J Gastroenterol       Date:  2010-07-25

Review 7.  Optimal therapy for Helicobacter pylori infections.

Authors:  Emiko Rimbara; Lori A Fischbach; David Y Graham
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

8.  Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil.

Authors:  Paula Prazeres Magalhães; Dulciene Maria De Magalhães Queiroz; Daniela Vale Campos Barbosa; Gifone Aguiar Rocha; Edilberto Nogueira Mendes; Adriana Santos; Paulo Renato Valle Corrêa; Andreia Maria Camargos Rocha; Lúcia Martins Teixeira; Celso Affonso de Oliveira
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 9.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.